BORTEZOMIB
Product Description
DCS Pharma USA
-
Country/Region:Switzerland
-
On CPHI since:2018
Categories
Specifications
DCS Pharma USA
-
Country/Region:Switzerland
-
On CPHI since:2018
More Products from DCS Pharma USA (2)
-
Product BENDAMUSTINE HCL
For sure Bendamustine HCl is of interest to your company. Our API has been successfully registered in several European countries and is currently being registered in the US. REGULATORY STATUS: GMP: NO but WC - US-DMF: YES - EU-DMF: YES - COA: EP USP - TSE/BSE: YES. www.dcspharma.com/bendamustine -
Product DAPAGLIFLOZIN
Dapagliflozin inhibits the protein responsible for delivering glucose into the bloodstream. REGULATORY STATUS: US-DMF: YES - US-FDA approval: Expected - EU-DMF: In preparation. www.dcspharma.com/dapagliflozin
DCS Pharma USA resources (1)
-
Brochure PORTFOLIO DCS PHARMA USA
YOUR API EXPERTS: The highest quality, specialized knowledge, and transparency: this is what we bring to active pharmaceutical ingredients.We are your specialists with clearly-defined schedules, extensive high-quality Swiss services, and a global network built up over decades. We focus on a few select therapeutic groups and set the right priorities.Because we’re quality-conscious.

